Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Population pharmacokinetics, pharmacodynamics and pharmacogenetics modelling of oxypurinol in Hmong adults with gout and/or hyperuricemia

British Journal of Clinical Pharmacology(2023)10.1111/bcp.15792Source: DataRank Database

Population pharmacokinetics, pharmacodynamics and pharmacogenetics modelling of oxypurinol in Hmong adults with gout and/or hyperuricemia is a research paper published in British Journal of Clinical Pharmacology (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

refsnp nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.50)OA: hybridTopics (50)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Richard C. Brundage ORCID,Youssef M. Roman ORCID,Kathleen A. Culhane‐Pera ORCID,Robert J. Straka ORCID,Ya‐Feng Wen ORCID

Live enrichment

PubMed:37202871 PMC:PMC10527451 OpenAlex:https://openalex.org/W4377093882

University of Minnesota

Grant: 22556

National Institutes of Health

Grant: UL1TR000114

NCATS NIH HHS

Grant: UL1 TR002494

National Institutes of Health

Grant: 3UL1TR000114-04S1

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)

FWCI

0.50

Citation Percentile

0.6%

Citation Trend

2024

2025

hybridLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.15792

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.15792

publisherhttps://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15792

journalhttps://doi.org/10.1111/bcp.15792

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37202871

Fields of Study

Gout, Hyperuricemia, Uric AcidAcute Lymphoblastic Leukemia researchThyroid Disorders and Treatments03 medical and health sciences0302 clinical medicineAdultHumansOxypurinolAllopurinolHyperuricemiaGout SuppressantsPharmacogeneticsGoutOrganic Anion TransportersOrganic Cation Transport Proteins

MeSH Terms

AdultAllopurinolGoutGout SuppressantsHumansOxypurinolPharmacogeneticsOrganic Anion TransportersOrganic Cation Transport ProteinsHyperuricemia

Keywords

AllopurinolPharmacodynamicsPharmacokineticsNONMEMMedicinePharmacologyPharmacogeneticsGoutPopulationHyperuricemiaRenal functionDosingInternal medicineGenotypeBiologyUric acidGeneticsPopulation PharmacokineticsPharmacometricsAdultOrganic Cation Transport ProteinsHumansOxypurinolOrganic Anion TransportersGout Suppressants

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being